ondansetron has been researched along with Asthma, Bronchial in 2 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kiernan, E | 1 |
| Jones, KL | 1 |
| Milne, RJ | 1 |
1 review available for ondansetron and Asthma, Bronchial
| Article | Year |
|---|---|
Medications that Cause Fetal Anomalies and Possible Prevention Strategies.
Topics: Abnormalities, Drug-Induced; Acetaminophen; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Analg | 2019 |
1 other study available for ondansetron and Asthma, Bronchial
| Article | Year |
|---|---|
Evaluation of the pharmacoeconomic literature.
Topics: Asthma; Bronchodilator Agents; Child; Cisplatin; Economics, Pharmaceutical; Forecasting; Humans; Ond | 1994 |